Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Partial Epilepsy”

119 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 119 results

Not applicableNot Yet RecruitingNCT04441008
What this trial is testing

Accelerated iTBS for Depression and Suicidality

Who this might be right for
Major Depressive DisorderSuicide
University of Iowa 50
Testing effectiveness (Phase 2)Looking for participantsNCT06422923
What this trial is testing

NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

Who this might be right for
Epilepsy, Temporal Lobe
Neurona Therapeutics 10
Testing effectiveness (Phase 2)Study completedNCT00144690
What this trial is testing

E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Inc.
Not applicableStudy completedNCT01745952
What this trial is testing

Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS)

Who this might be right for
Epilepsies, Partial
Universitaire Ziekenhuizen KU Leuven 11
Large-scale testing (Phase 3)Study completedNCT00957372
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 253
Not applicableStudy completedNCT03419000
What this trial is testing

Circulating microRNAs as Biomarkers of RESPIratory Dysfunction in Patients With Refractory epilePSY

Who this might be right for
Drug Resistant Epilepsy
Hospices Civils de Lyon 75
Post-approval studies (Phase 4)Study completedNCT01278173
What this trial is testing

The Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)

Who this might be right for
Adult Refractory Complex Partial Seizures
Lundbeck LLC 65
Large-scale testing (Phase 3)Study completedNCT01618695
What this trial is testing

A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures

Who this might be right for
Partial-onset Seizures
Eisai Co., Ltd. 940
Testing effectiveness (Phase 2)Study completedNCT02170077
What this trial is testing

A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093

Who this might be right for
Epilepsy
Bial - Portela C S.A. 144
Large-scale testing (Phase 3)Study completedNCT02076698
What this trial is testing

Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy

Who this might be right for
Partial EpilepsySurgery
University Hospital, Grenoble 62
Not applicableUnknownNCT04383028
What this trial is testing

MELD as an Adjunct for SEEG Trajectories

Who this might be right for
EpilepsyEpilepsy, FocalEpilepsy, Refractory
Great Ormond Street Hospital for Children NHS Foundation Trust 20
Large-scale testing (Phase 3)Study completedNCT00113815
What this trial is testing

Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

Who this might be right for
Partial Seizure DisorderEpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 118
Not applicableEnded earlyNCT00382707
What this trial is testing

Transcranial Magnetic Stimulation and Anti-epileptic Effect: Optimization and Evaluation With Electrophysiology.

Who this might be right for
Refractory Frontal Lobe Epilepsy
University Hospital, Strasbourg, France 15
Not applicableStudy completedNCT02866240
What this trial is testing

Safety and Therapeutic Measures of Tdcs in Patients With Refractory Focal Epilepsy

Who this might be right for
Refractory Epilepsy
Neuroelectrics Corporation 20
Testing effectiveness (Phase 2)Study completedNCT00236691
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 188
Very early researchUnknownNCT05886205
What this trial is testing

Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Refractory Focal Epilepsy

Who this might be right for
Refractory Focal Epilepsy
Peking Union Medical College Hospital 34
Testing effectiveness (Phase 2)Study completedNCT00849212
What this trial is testing

An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs)

Who this might be right for
Refractory Partial Seizures
Eisai Co., Ltd. 30
Not applicableApproved For MarketingNCT00918424
What this trial is testing

Long Term Study of the Safety of OXC XR as in Pediatric Epilepsy Subjects

Who this might be right for
Epilepsy
Supernus Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT00772603
What this trial is testing

Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures

Who this might be right for
Epilepsies, Partial
Supernus Pharmaceuticals, Inc. 366
Early research (Phase 1)Study completedNCT00918047
What this trial is testing

Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients

Who this might be right for
Epilepsies, Partial
Supernus Pharmaceuticals, Inc. 18
Next Page